Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery

Omid Veiseh, Forrest M. Kievit, Hyejung Mok, Joseph Ayesh, Cassra Clark, Chen Fang, Matthew Leung, Hamed Arami, James O. Park, Miqin Zhang

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Lack of safe and effective carriers for delivery of RNA therapeutics remains a barrier to its broad clinical application. We report the development of a cell tanscytosing magnetic nanovector engineered as an siRNA carrier. Iron oxide nanoparticles were modified with poly(ethylene glycol) (PEG), small interfering RNA (siRNA), and a cationic polymer layer. Three nanovector formulations with cationic polymer coatings of poly-arginine (pArg), polylysine (pLys), and polyethylenimine (PEI), respectively, were prepared. The three nanovector formulations where evaluated for safety and ability to promote gene silencing in three types of cancer cells C6/GFP+, MCF7/GFP+, and TC2/GFP+, mimicking human cancers of the brain, breast, and prostate, respectively. Cell viability and fluorescence quantification assays revealed that pArg-coated nanovectors were most effective in promoting gene knockdown and least toxic of the three nanovector formulations tested. Transmission electron microscopy (TEM) imaging of nanovector treated cells further demonstrated that pArg-coated nanovectors enter cells through cell transcytosis, while pLys and PEI coated nanovectors enter cells endocytosis. Our findings suggest that NPs engineered to exploit the cell transcytosis intracellular trafficking pathway may offer a more safe and efficient route for siRNA delivery.

Original languageEnglish (US)
Pages (from-to)5717-5725
Number of pages9
JournalBiomaterials
Volume32
Issue number24
DOIs
StatePublished - Aug 1 2011

Fingerprint

Arginine
RNA
Small Interfering RNA
Polyethyleneimine
Polylysine
Cells
Polyethylene glycols
Polymers
Genes
Poisons
Transcytosis
Assays
Brain
Fluorescence
Iron oxides
Nanoparticles
Transmission electron microscopy
Imaging techniques
Coatings
Gene Knockdown Techniques

Keywords

  • Cancer
  • Gene therapy
  • Iron oxide nanoparticle
  • MRI
  • SiRNA
  • Transcytosis

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. / Veiseh, Omid; Kievit, Forrest M.; Mok, Hyejung; Ayesh, Joseph; Clark, Cassra; Fang, Chen; Leung, Matthew; Arami, Hamed; Park, James O.; Zhang, Miqin.

In: Biomaterials, Vol. 32, No. 24, 01.08.2011, p. 5717-5725.

Research output: Contribution to journalArticle

Veiseh, O, Kievit, FM, Mok, H, Ayesh, J, Clark, C, Fang, C, Leung, M, Arami, H, Park, JO & Zhang, M 2011, 'Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery', Biomaterials, vol. 32, no. 24, pp. 5717-5725. https://doi.org/10.1016/j.biomaterials.2011.04.039
Veiseh, Omid ; Kievit, Forrest M. ; Mok, Hyejung ; Ayesh, Joseph ; Clark, Cassra ; Fang, Chen ; Leung, Matthew ; Arami, Hamed ; Park, James O. ; Zhang, Miqin. / Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. In: Biomaterials. 2011 ; Vol. 32, No. 24. pp. 5717-5725.
@article{c79d774c3d5d48468c51794d98adf981,
title = "Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery",
abstract = "Lack of safe and effective carriers for delivery of RNA therapeutics remains a barrier to its broad clinical application. We report the development of a cell tanscytosing magnetic nanovector engineered as an siRNA carrier. Iron oxide nanoparticles were modified with poly(ethylene glycol) (PEG), small interfering RNA (siRNA), and a cationic polymer layer. Three nanovector formulations with cationic polymer coatings of poly-arginine (pArg), polylysine (pLys), and polyethylenimine (PEI), respectively, were prepared. The three nanovector formulations where evaluated for safety and ability to promote gene silencing in three types of cancer cells C6/GFP+, MCF7/GFP+, and TC2/GFP+, mimicking human cancers of the brain, breast, and prostate, respectively. Cell viability and fluorescence quantification assays revealed that pArg-coated nanovectors were most effective in promoting gene knockdown and least toxic of the three nanovector formulations tested. Transmission electron microscopy (TEM) imaging of nanovector treated cells further demonstrated that pArg-coated nanovectors enter cells through cell transcytosis, while pLys and PEI coated nanovectors enter cells endocytosis. Our findings suggest that NPs engineered to exploit the cell transcytosis intracellular trafficking pathway may offer a more safe and efficient route for siRNA delivery.",
keywords = "Cancer, Gene therapy, Iron oxide nanoparticle, MRI, SiRNA, Transcytosis",
author = "Omid Veiseh and Kievit, {Forrest M.} and Hyejung Mok and Joseph Ayesh and Cassra Clark and Chen Fang and Matthew Leung and Hamed Arami and Park, {James O.} and Miqin Zhang",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.biomaterials.2011.04.039",
language = "English (US)",
volume = "32",
pages = "5717--5725",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "24",

}

TY - JOUR

T1 - Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery

AU - Veiseh, Omid

AU - Kievit, Forrest M.

AU - Mok, Hyejung

AU - Ayesh, Joseph

AU - Clark, Cassra

AU - Fang, Chen

AU - Leung, Matthew

AU - Arami, Hamed

AU - Park, James O.

AU - Zhang, Miqin

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Lack of safe and effective carriers for delivery of RNA therapeutics remains a barrier to its broad clinical application. We report the development of a cell tanscytosing magnetic nanovector engineered as an siRNA carrier. Iron oxide nanoparticles were modified with poly(ethylene glycol) (PEG), small interfering RNA (siRNA), and a cationic polymer layer. Three nanovector formulations with cationic polymer coatings of poly-arginine (pArg), polylysine (pLys), and polyethylenimine (PEI), respectively, were prepared. The three nanovector formulations where evaluated for safety and ability to promote gene silencing in three types of cancer cells C6/GFP+, MCF7/GFP+, and TC2/GFP+, mimicking human cancers of the brain, breast, and prostate, respectively. Cell viability and fluorescence quantification assays revealed that pArg-coated nanovectors were most effective in promoting gene knockdown and least toxic of the three nanovector formulations tested. Transmission electron microscopy (TEM) imaging of nanovector treated cells further demonstrated that pArg-coated nanovectors enter cells through cell transcytosis, while pLys and PEI coated nanovectors enter cells endocytosis. Our findings suggest that NPs engineered to exploit the cell transcytosis intracellular trafficking pathway may offer a more safe and efficient route for siRNA delivery.

AB - Lack of safe and effective carriers for delivery of RNA therapeutics remains a barrier to its broad clinical application. We report the development of a cell tanscytosing magnetic nanovector engineered as an siRNA carrier. Iron oxide nanoparticles were modified with poly(ethylene glycol) (PEG), small interfering RNA (siRNA), and a cationic polymer layer. Three nanovector formulations with cationic polymer coatings of poly-arginine (pArg), polylysine (pLys), and polyethylenimine (PEI), respectively, were prepared. The three nanovector formulations where evaluated for safety and ability to promote gene silencing in three types of cancer cells C6/GFP+, MCF7/GFP+, and TC2/GFP+, mimicking human cancers of the brain, breast, and prostate, respectively. Cell viability and fluorescence quantification assays revealed that pArg-coated nanovectors were most effective in promoting gene knockdown and least toxic of the three nanovector formulations tested. Transmission electron microscopy (TEM) imaging of nanovector treated cells further demonstrated that pArg-coated nanovectors enter cells through cell transcytosis, while pLys and PEI coated nanovectors enter cells endocytosis. Our findings suggest that NPs engineered to exploit the cell transcytosis intracellular trafficking pathway may offer a more safe and efficient route for siRNA delivery.

KW - Cancer

KW - Gene therapy

KW - Iron oxide nanoparticle

KW - MRI

KW - SiRNA

KW - Transcytosis

UR - http://www.scopus.com/inward/record.url?scp=79957926113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957926113&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2011.04.039

DO - 10.1016/j.biomaterials.2011.04.039

M3 - Article

C2 - 21570721

AN - SCOPUS:79957926113

VL - 32

SP - 5717

EP - 5725

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 24

ER -